Geetha Puthenveetil, MD
Office and Contact Information
CHOC Children's Specialists
1201 W La Veta
Orange, CA 92868
phone: (714) 509-8459
fax: (714) 509-8771
map & directions
Physician / Researcher BioGeetha Puthenveetil, MD specializes in all aspects of hematology with emphasis in hemoglobinopathies, including Beta Thalassemia and Sickle Cell disease. Dr. Puthenveetil is board certified in pediatrics and in pediatric hematology-oncology. She received her medical degree from St. John's Medical College in Karnataka, India. She completed pediatric residency training at St. John's Medical College Hospital and at New York Medical College in Valhalla, New York. She completed a pediatric hematology-oncology fellowship at Children's Hospital Los Angeles/University of Southern California.
ResearchDr. Putheveetil is part of the national sickle cell network. She is currently part of an international study looking at standards of care with sickle cell patients. Helping to facilitate this research, Dr. Putheveetil established a comprehensive red cell clinic at CHOC to treat patients with red cell disorders—including sickle cell disease, thalassemia, aplastic anemia, and Diamond-Blackfan Anemia. The clinic is attended by a cardiologist, endocrinologist, and hematologist and provides comprehensive care for patients.
- Medical School
St John's Medical College, Bangalore, Karnataka, India
- Pediatrics Residency
New York Medical College/Westchester Medical Center, Valhalla, NY
- Pediatric Hematology/Oncology Fellowship
Children's Hospital of Los Angeles, CA
- Pediatric Hematology/Oncology
Honors and Awards
- Excellence in Research Award from the American Society of Gene Therapy in 2004
- Physician of Excellence award for 2009 through 2012 from the Orange County Medical Association.
Sickle Cell Disease: Dr. Puthenveetil, CHOC Children's
In this American Health Jounrnal video Geetha Puthenveetil, MD, explains the disorder of sicle cell anemia and talks about one of the most common myths of the disease. ...
|Dr. Geetha Puthenveetil to Appear on American Health Journal on Thursday, December 27th at 12:30 p.m.
December 19, 2012
|More than 80 CHOC Children's Doctors Named "Physicians of Excellence"
January 03, 2012
More than 80 CHOC Children's physicians, including specialists and pediatricians, are named "Physicians of Excellence" by the Orange County Medical Association....
|More than 60 CHOC Children’s Doctors Named “Physicians of Excellence”
January 04, 2011
More than 60 CHOC Children’s physicians, including specialists and pediatricians, are featured as "Physicians of Excellence" in the January 2011 issue of Orange Coast magazine. The "Physicians of Exc...
|More than 50 CHOC Children's Doctors Named "Physicians of Excellence"
January 04, 2010
The Orange County Medical Association names more than 50 CHOC doctors "Physicians of Excellence."...
Buchbinder D, Nugent D, Vu D, Soni A, Stites J, Hsieh L, Puthenveetil G. Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload. Pediatr Transplant. 2010 Nov 26. doi: 10.1111/j.1399-3046.2010.01414.x. [Epub ahead of print]
Malik P, Arumugam PI, Yee JK, Puthenveetil G Successful Correction of the Human Cooley’s Anemia (beta) – Thalassemia Major Phenotype Using a Lentiviral Vector Flanked by the Chicken Hypersensitive Site 4 Chromatin Insulator. Ann N Y Acad Sci. 2005 Nov; 1054:238-49. Review
Puthenveetil G, Scholes J, Carbonell D, Qureshi N, Xia P, Zeng L, Li S, Yu Y, Hiti AL, Yee JK, Malik P. Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood. 2004 Dec 1;104(12):3445-53. Epub 2004 Aug 3.
Puthenveetil G, Malik P. Gene Therapy for Hemoglobinopathies :Are we there yet? Curr Hematol Rep. 2004 Jul;3(4):298-305. Review.
Effect of Immune Therapy on PNH Clone Size and Bone Marrow Cellularity. David Shyr MD, Geetha Puthenveetil MD, Children’s Hospital of Orange County. Abstract accepted for a poster presentation at the Annual meeting of the American Society of Pediatric Hematology/Oncology in April 2010
New Approach in treating pediatric Hemangiomas . Jill Stites FNP, Geetha Puthenveetil MD, Children’s Hospital of Orange County Abstract accepted for a poster presentation at the Annual meeting of the American Society of Pediatric Hematology/Oncology in April 2010
Deferasirox is a safe and effective iron chelator in thalassemia patients post bone marrow transplantation – Poster presentation – Ninth Cooley’s Anemia Symposium, 10/09
Below is information removed from this biography that the subject specifically requested be included:
- “Successful Correction of the Human Beta Thalassemia Major Phenotype Using a Lentiviral Vector” for the journal, Blood, 2004
- “Successful Correction of the Human Cooley’s Anemia (beta) – Thalassemia Major Phenotype Using a Lentiviral Vector Flanked by the Chicken Hypersensitive Site 4 Chromatin Insulator” for the Annals of the New York Academy of Sciences, 2005
- Presented on deferasirox as a safe and effective iron chelator in thalassemia patients post bone marrow transplantation at the Ninth Colley’s Anemia Symposium.
- In 2010 at the annual meeting for the American Society of Pediatric Hematology/Oncology, Dr. Petheveetil coauthored the poster presentations “New Approach in Treating Pediatric Hemangiomas” and “The Effect of Immune Therapy on PNH Cone Size and Bone Marrow Cellularity.”
- “Unrelated Hematopoietic Stem Cell Transplantation in a Patient with Congenital Dyserythropoietic Aneia and Iron Overload” accepted for publication in Pediatric Transplantation, the official journal of the International Pediatric Transplant Association.